Hypertension and diabetes and the Fosinopril versus Amlodipine Cardiovascular Events Trial (FACET) - More ammunition against surrogate end points

被引：14

作者：

Califf, RM

Granger, CB

机构：

[1] Duke Univ, Med Ctr, Duke Clin Res Inst, Durham, NC 27705 USA

[2] Duke Univ, Med Ctr, Dept Med, Div Cardiol, Durham, NC 27705 USA

来源：

DIABETES CARE | 1998年 / 21卷 / 04期

关键词：

D O I：

10.2337/diacare.21.4.655

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：655 / 657

页数：3

共 16 条

[1] HIRUDIN IN ACUTE MYOCARDIAL-INFARCTION - SAFETY REPORT FROM THE THROMBOLYSIS AND THROMBIN INHIBITION IN MYOCARDIAL-INFARCTION (TIMI)-9A TRIAL
ANTMAN, EM
[J]. CIRCULATION, 1994, 90 (04) : 1624 - 1630
[2] MORTALITY AND MORBIDITY IN PATIENTS RECEIVING ENCAINIDE, FLECAINIDE, OR PLACEBO - THE CARDIAC-ARRHYTHMIA SUPPRESSION TRIAL
ECHT, DS
LIEBSON, PR
MITCHELL, LB
PETERS, RW
OBIASMANNO, D
BARKER, AH
ARENSBERG, D
BAKER, A
FRIEDMAN, L
GREENE, HL
HUTHER, ML
RICHARDSON, DW
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (12) : 781 - 788
[3] MORTALITY FOLLOWING VENTRICULAR ARRHYTHMIA SUPPRESSION BY ENCAINIDE, FLECAINIDE, AND MORICIZINE AFTER MYOCARDIAL-INFARCTION - THE ORIGINAL DESIGN CONCEPT OF THE CARDIAC-ARRHYTHMIA SUPPRESSION TRIAL (CAST)
EPSTEIN, AE
HALLSTROM, AP
ROGERS, WJ
LIEBSON, PR
SEALS, AA
ANDERSON, JL
COHEN, JD
CAPONE, RJ
WYSE, DG
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1993, 270 (20): : 2451 - 2455
[4] Surrogate end points in clinical trials: Are we being misled?
Fleming, TR
DeMets, DL
[J]. ANNALS OF INTERNAL MEDICINE, 1996, 125 (07) : 605 - 613
[5] NIFEDIPINE - DOSE-RELATED INCREASE IN MORTALITY IN PATIENTS WITH CORONARY HEART-DISEASE
FURBERG, CD
PSATY, BM
MEYER, JV
[J]. CIRCULATION, 1995, 92 (05) : 1326 - 1331
[6] SAFETY OBSERVATIONS FROM THE PILOT PHASE OF THE RANDOMIZED R-HIRUDIN FOR IMPROVEMENT OF THROMBOLYSIS (HIT-III) STUDY - A STUDY OF THE ARBEITSGEMEINSCHAFT-LEITENDER-KARDIOLOGISCHER-KRANKENHAUSARZTE (ALKK)
NEUHAUS, KL
VONESSEN, R
TEBBE, U
JESSEL, A
HEINRICHS, H
MAURER, W
DORING, W
HARMJANZ, D
KOTTER, V
KALHAMMER, E
SIMON, H
HORACEK, T
[J]. CIRCULATION, 1994, 90 (04) : 1638 - 1642
[7] EFFECT OF ORAL MILRINONE ON MORTALITY IN SEVERE CHRONIC HEART-FAILURE
PACKER, M
CARVER, JR
RODEHEFFER, RJ
IVANHOE, RJ
DIBIANCO, R
ZELDIS, SM
HENDRIX, GH
BOMMER, WJ
ELKAYAM, U
KUKIN, ML
MALLIS, GI
SOLLANO, JA
SHANNON, J
TANDON, PK
DEMETS, DL
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1991, 325 (21) : 1468 - 1475
[8] LARGE-SCALE RANDOMIZED EVIDENCE - LARGE, SIMPLE TRIALS AND OVERVIEWS OF TRIALS
PETO, R
COLLINS, R
GRAY, R
[J]. JOURNAL OF CLINICAL EPIDEMIOLOGY, 1995, 48 (01) : 23 - 40
[9] SURROGATE ENDPOINTS IN CLINICAL-TRIALS - DEFINITION AND OPERATIONAL CRITERIA
PRENTICE, RL
[J]. STATISTICS IN MEDICINE, 1989, 8 (04) : 431 - 440
[10] Conflict of interest in the debate over calcium-channel antagonists
Stelfox, HT
Chua, G
O'Rourke, K
Detsky, AS
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (02) : 101 - 106

← 1 2 →